Genome expression analysis by suppression subtractive hybridization identified overexpression of Humanin, a target gene in gastric cancer chemoresistance

DARU, Journal of Pharmaceutical Sciences

Volumn 22, Issue 1, 2014, Pages

  Mottaghi Dastjerdi, Negar ^a,b   Soltany Rezaee Rad, Mohammad ^a,b   Sepehrizadeh, Zargham ^a   Roshandel, Gholamreza ^c   Ebrahimifard, Farzaneh ^d   Setayesh, Neda ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Chemoresistance; Gastric cancer; Humanin; Suppression subtractive hybridization

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; HUMANIN; HUMANIN 1; HUMANIN 10; HUMANIN 3; HUMANIN 6; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; UPREGULATION;

EID: 84892717084     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-22-14     Document Type: Article

References (32)

1. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Bray F, Ren JS, Masuyer E, Ferlay J, Int J Cancer 2013 132 5 1133 1145 10.1002/ijc.27711 22752881
2. Gastric cancer: diagnosis and treatment options. Layke JC, Lopez PP, Am Fam Physician 2004 69 5 1133 15023013
3. Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Yamashita K, Sakuramoto S, Watanabe M, Surg Today 2011 41 1 24 38 10.1007/s00595-010-4370-5 21191688
4. Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. Nagini S, World J Gastrointest Oncol 2012 4 7 156 10.4251/wjgo.v4.i7.156 22844547
5. Helicobacter pylori and gastric cancer in the Middle East: a new enigma? Hussein NR, WJG 2010 16 26 3226 10.3748/wjg.v16.i26.3226 20614477
6. Clinical implications of chromosomal abnormalities in gastric adenocarcinomas. Wu CW, Chen GD, Fann CSJ, Lee AFY, Chi CW, Liu JM, Weier U, Chen JY, Genes Chromosom Cancer 2002 35 3 219 231 10.1002/gcc.10106 12353264
7. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Hou Q, Wu YH, Grabsch H, Zhu Y, Leong SH, Ganesan K, Cross D, Tan LK, Tao J, Gopalakrishnan V, Cancer Res 2008 68 12 4623 4630 10.1158/0008-5472.CAN-07-5870 18559507
8. Chemoresistance in solid tumours. Wilson T, Longley D, Johnston P, Ann Oncol 2006 17 suppl 10 315 324 10.1093/annonc/mdl280
9. Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Oki E, Baba H, Tokunaga E, Nakamura T, Ueda N, Futatsugi M, Mashino K, Yamamoto M, Ikebe M, Kakeji Y, Maehara Y, Int J Cancer 2005 117 3 376 380 10.1002/ijc.21170 15900596
10. Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells. Tyson JJ, Baumann WT, Chen C, Verdugo A, Tavassoly I, Wang Y, Weiner LM, Clarke R, Nat Rev Cancer 2011 11 7 523 532 10.1038/nrc3081 21677677
11. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Diatchenko L, Lau Y, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Proc Natl Acad Sci 1996 93 12 6025 6030 10.1073/pnas.93.12.6025 8650213
12. Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Tajima H, Niikura T, Hashimoto Y, Ito Y, Kita Y, Terashita K, Yamazaki K, Koto A, Aiso S, Nishimoto I, Neurosci Lett 2002 324 3 227 231 10.1016/S0304-3940(02)00199-4 12009529
13. Evidence for potential functionality of nuclearly-encoded humanin isoforms. Bodzioch M, Lapicka-Bodzioch K, Zapala B, Kamysz W, Kiec-Wilk B, Dembinska-Kiec A, Genomics 2009 94 4 247 256 10.1016/j.ygeno.2009.05.006 19477263
14. Humanins, the neuroprotective and cytoprotective peptides with antiapoptotic and anti-inflammatory properties. Zapala B, Kaczynski L, Kiec-Wilk B, Staszel T, Knapp A, Thoresen GH, Wybranska I, Dembinska-Kiec A, Pharmacol Rep 2010 62 5 767 777 21098860
15. Humanin peptide suppresses apoptosis by interfering with Bax activation. Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, Satterthwait AC, Reed JC, Nature 2003 423 6938 456 461 10.1038/nature01627 12732850
16. Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Diatchenko L, Lukyanov S, Lau Y-FC, Siebert PD, Methods Enzymol 1999 303 349 380 10349654
17. Analysis of relative gene expression data using real-time quantitative PCR and the 2-Δ Δ C T Method. Livak KJ, Schmittgen TD, Methods 2001 25 4 402 408 10.1006/meth.2001.1262 11846609
18. Gastric cancer in Iran: epidemiology and risk factors. Malekzadeh R, Derakhshan MH, Malekzadeh Z, Arch Iran Med 2009 12 6 576 583 19877751
19. Defective apoptosis underlies chemoresistance in ovarian cancer. Hajra KM, Tan L, Liu JR, Ovarian Cancer. Volume 622 New York: Springer, Coukos G, Berchuck A, Ozols R, 2008 197 208
20. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M, Biochem Pharmacol 2008 76 11 1340 1351 10.1016/j.bcp.2008.07.031 18755156
21. Humanin: a harbinger of mitochondrial-derived peptides? Lee C, Yen K, Cohen P, Trends Endocrinol Metab 2013
22. Unravelling the role of Humanin. Nishimoto I, Matsuoka M, Niikura T, Trends Mol Med 2004 10 3 102 105 10.1016/j.molmed.2004.01.001 15106598
23. The emerging role of the mitochondrial-derived peptide humanin in stress resistance. Yen K, Lee C, Mehta H, Cohen P, J Mol Endocrinol 2013 50 1 11 R19 10.1530/JME-12-0203 23239898
24. Humanin inhibits cell death of serum-deprived PC12h cells. Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S, Neuroreport 2002 13 6 903 907 10.1097/00001756-200205070-00034 11997711
25. Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein. Hashimoto Y, Ito Y, Niikura T, Shao Z, Hata M, Oyama F, Nishimoto I, Biochem Biophys Res Commun 2001 283 2 460 468 10.1006/bbrc.2001.4765 11327724
26. The cytoplasmic domain of Alzheimer's amyloid-β protein precursor causes sustained apoptosis signal-regulating kinase 1/c-Jun NH2-terminal kinase-mediated neurotoxic signal via dimerization. Hashimoto Y, Niikura T, Chiba T, Tsukamoto E, Kadowaki H, Nishitoh H, Yamagishi Y, Ishizaka M, Yamada M, Nawa M, J Pharmacol Exp Ther 2003 306 3 889 902 10.1124/jpet.103.051383 12829723
27. Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Ikonen M, Liu B, Hashimoto Y, Ma L, Lee K-W, Niikura T, Nishimoto I, Cohen P, Proc Natl Acad Sci 2003 100 22 13042 13047 10.1073/pnas.2135111100 14561895
28. Humanin rescues human cerebrovascular smooth muscle cells from Aβ-induced toxicity. Jung SS, Van Nostrand WE, J Neurochem 2003 84 2 266 272 10.1046/j.1471-4159.2003.01524.x 12558989
29. Humanin delays apoptosis in K562 cells by downregulation of P38 MAP kinase. Wang D, Li H, Yuan H, Zheng M, Bai C, Chen L, Apoptosis 2005 10 5 963 971 10.1007/s10495-005-1191-x 16151632
30. Humanin improves impaired metabolic activity and prolongs survival of serum-deprived human lymphocytes. Kariya S, Takahashi N, Hirano M, Ueno S, Mol Cell Biochem 2003 254 1-2 83 89 14674685
31. Effect of humanin on decreased ATP levels of human lymphocytes harboring A3243G mutant mitochondrial DNA. Kariya S, Hirano M, Furiya Y, Ueno S, Neuropeptides 2005 39 2 97 101 10.1016/j.npep.2004.11.004 15752543
32. Post-transcriptional regulation in cancer. Audic Y, Hartley RS, Biol Cell 2004 96 7 479 498 10.1016/j.biolcel.2004.05.002 15380615